The Pharmacy Times® Retail Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to retail, community, and independent pharmacists.
July 1st 2025
Simplifying complex information through illustrations has consistently helped patients feel that managing type 1 diabetes is achievable.
Semaglutide Carries Potential Risk of Worsening Diabetic Retinopathy
Despite demonstrating numerous benefits, semaglutide has also been linked to an increased incidence of diabetic retinopathy, which was initially reported in the SUSTAIN-6 trial.
Read More
Expert: Pharmacists, USP Worked Together ‘A Hundred Times Faster Than Ever Before’ in 2021
December 22nd 2021Ronald T. Piervincenzi, PhD, CEO of US Pharmacopeia, explains how pharmacists and USP came together in 2021 to work harder than ever before, as well as what can be done now to prepare for the next health crisis.
Watch
TXNIP inhibitors: A New Class of Agents for Diabetes Treatment
TXNIP inhibition could prevent beta cell loss and protect beta cell function to potentially contribute to diabetes management and its complications.
Read More
Expert: USP, Pharmacy Came Together in 2021 to Create Vaccine Toolkits ‘For Every Vaccine Created’
December 20th 2021Ronald T. Piervincenzi, PhD, CEO of US Pharmacopeia, discusses what stands out as the biggest challenge from the past year and what role USP and pharmacists had in overcoming that challenge.
Watch
Safety, Efficacy of Dara-KRd in Treatment of Patients With Newly Diagnosed Multiple Myeloma
December 20th 2021Luciano Costa, MD, PhD, associate director for clinical research at the O’Neal Comprehensive Cancer Center at the University of Alabama at Birmingham, on the safety and efficacy of Dara-KRd in the treatment of patients with newly diagnosed multiple myeloma.
Watch
Expert: The NIH ORWH Ensures ‘Women's Health Research Is Part of the Scientific Framework of NIH’
December 20th 2021Sarah Temkin, MD, associate director for clinical research in the Office of Research on Women’s Health (ORWH) at the National Institutes of Health (NIH), discusses how the work of the NIH ORWH impacts pharmacy practice.
Watch
APhA Releases Statement Addressing Pharmacist Burnout, Calls for Change
December 20th 2021The Board of Trustees of APhA addresses 5 areas in their statement, including importance of wellbeing, root causes of pharmacist burnout, pharmacy benefit manager issues, need for provider status, and some potential solutions.
Read More